A promising approach for therapy control in congenital adrenal hyperplasia. Problems of Endocrinology
Problems of Endocrinology · 2024
DOI: 10.14341/probl13328 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Problems of Endocrinology, 2024. Verfasst von M A Tiulpakov und 3 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Research Centre. Hauptthemen laut MEDLINE: Adrenal Hyperplasia, Congenital, Puberty, Precocious. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: US Non-government Organization.
Abstract (Originalsprache)
Congenital adrenal hyperplasia (CAH) is a group of autosomal recessive disorders requiring lifelong glucocorticoid replacement (GC) therapy. Lack of GC therapy leads to precocious puberty in boys, heterosexual development in girls, accelerated bone maturation and short final height in both sexes. In adolescence, the lack of GC therapy is the cause of menstrual disorders in girls and the development of TART in boys, as a result reducing the reproductive potential in both sexes. On the other hand, an overdose of GC leads to drug-induced Itsenko-Cushing’s syndrome. In order to select adequate doses of GC in childhood and adolescence, multiple determinations of 17-hydroxyprogesterone, androstenedione, and testosterone in blood plasma, and thus multiple venous blood sampling are required. The blood sampling requires specially trained medical staff and can effect on the results due to stress reaction especially in young patients. Hence, the development and implementation of a non-invasive method for determining the steroid profile is extremely important in monitoring GC therapy in children. In addition, the currently used immunofluorescence assay cannot determine other adrenal steroids, has a high variation due to the «cross-reaction» of steroids that are similar in structure, which inflates the results. Unlike immunofluorescence assay, liquid chromatography and tandem mass spectrometry is more preferable method, since it is more specific and accurate. In this literature review, saliva presented as an alternative substrate and the non-invasive method for determining the steroid profile. This method can solve the above disadvantages, simplify and make more accurate the selection of GC therapy in patients with CAH, which is especially important in childhood.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Endocrinology Research Centre.
Förderung
- US Non-government Organization
Zitieren
APA
Tiulpakov, M. A., Nagaeva, E. V., Kalinchenko, N. Y., & Bezlepkina, O. B. (2024). A promising approach for therapy control in congenital adrenal hyperplasia. Problems of Endocrinology. Problems of Endocrinology. https://doi.org/10.14341/probl13328
Vancouver
Tiulpakov MA, Nagaeva EV, Kalinchenko NY, Bezlepkina OB. A promising approach for therapy control in congenital adrenal hyperplasia. Problems of Endocrinology. Problems of Endocrinology. 2024. doi:10.14341/probl13328
BibTeX
@article{Tiulpakov2024,
author = {Tiulpakov, M A and Nagaeva, E V and Kalinchenko, N Y and Bezlepkina, O B},
title = {A promising approach for therapy control in congenital adrenal hyperplasia. Problems of Endocrinology},
journal = {Problems of Endocrinology},
year = {2024},
doi = {10.14341/probl13328}
}
EUVIMED